Skip to main content

Amneal Pharmaceuticals, Inc.

AMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723128

In the last 90 days, Amneal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $2.82B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Amneal Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of AMRX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders1281144+17
Shares97.5M1.58K101.9M+4.44M (+4.6%)
Value$302.0M$4.91K$430.0M+$128.0M (+42.4%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to AMRX in Q3 2023
InstitutionSharesValue% of portfolio
EAM Investors, LLC230,271$971.7K0.19%
Putnam Investments LLC152,621$644.1K0.00%
Point72 Asset Management, L.P.124,000$523.3K0.00%
Caxton Associates LP120,280$507.6K0.07%
Renaissance Technologies LLC114,100$482.0K0.00%
O'Shaughnessy Asset Management, LLC102,777$433.7K0.01%
Jane Street Group, LLC101,671$429.1K0.00%
Tejara Capital Ltd96,672$408.0K0.23%
PDT Partners, LLC88,008$371.4K0.05%
Ritholtz Wealth Management81,288$343.0K0.02%
Federated Hermes, Inc.78,259$330.3K0.00%
Franklin Resources Inc75,964$320.6K0.00%
Jump Financial, LLC74,800$315.7K0.01%
SG Americas Securities, LLC52,455$221.0K0.00%
ExodusPoint Capital Management, LP47,484$200.0K0.00%
Hillsdale Investment Management Inc.43,619$184.1K0.02%
Public Employees Retirement System of Ohio37,800$160.0K0.00%
Centiva Capital, LP31,912$134.7K0.01%
Old Mission Capital LLC31,064$131.1K0.00%
Squarepoint Ops LLC31,020$130.9K0.00%
Balyasny Asset Management LLC29,594$124.9K0.00%
Envestnet Asset Management Inc28,486$120.2K0.00%
Aigen Investment Management, LP27,905$117.8K0.02%
State of Wisconsin Investment Board22,700$95.8K0.00%
Verition Fund Management LLC17,400$73.4K0.00%
Nebula Research & Development LLC13,039$55.0K0.03%
Sherbrooke Park Advisers LLC12,822$54.1K0.02%
HSBC Holdings PLC11,433$47.9K0.00%
Gladius Capital Management LP9,226$38.9K0.01%
Comerica Bank1,329$5.61K0.00%
Cubist Systematic Strategies, LLC241$1.02K0.00%
Allworth Financial LP130$5490.00%

Sold out (15)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (1)

Institutions that held Amneal Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AMRX in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Coastal Capital Group, Inc.1,584$4.91K